$LYEL
Lyell Immunopharma, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$8.56
▼-0.58%-$0.050
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLyell Immunopharma, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is LYEL down today? It is at $8.56 (-0.58%), and our scanner flagged it 12 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LYEL spikes, and full due diligence on LYEL — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LYEL 12 times in the last 30 days. Create a free account to track $LYEL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LYEL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LYEL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 10, 2026 · 26 days agoThe company is cleared to issue new shares on demand, but has not yet. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Shook David Officer | Sold (automatic/other) | -500 | sold 2.4% | 20K | $6K at $12.70 | Sep 10, 26 |
Lee Gary K. Officer | Sold (automatic/other) | -1K | sold 8.2% | 16K | $23K at $15.54 | Aug 21, 26 |
Hill Stephen J. Officer | Sold (automatic/other) | -989 | sold 5.6% | 17K | $15K at $15.54 | Aug 21, 26 |
Seely Lynn Officer | Sold (automatic/other) | -10K 0.04% of company | sold 13% | 64K | $149K at $15.54 | Aug 21, 26 |
Seely Lynn Officer | Sold (automatic/other) | -390 | sold 0.5% | 73K | $6K at $14.34 | Aug 10, 26 |
Hill Stephen J. Officer | Sold (automatic/other) | -89 | sold 0.5% | 18K | $1K at $14.34 | Aug 10, 26 |
Lee Gary K. Officer | Sold (automatic/other) | -131 | sold 0.7% | 18K | $2K at $14.34 | Aug 10, 26 |
Bulis Veronica Sanchez Officer | Sold (automatic/other) | -621 | sold 4.0% | 15K | $9K at $14.34 | Aug 10, 26 |
Innovative Cellular Therapeutics Holdings Ltd Beneficial Owner (10%) | Sold (automatic/other) | -39K 0.2% of company | sold 1.3% | 2.82M | n/a | Jul 27, 26 |
Innovative Cellular Therapeutics Holdings Ltd Beneficial Owner (10%) | Sold (automatic/other) | -44K 0.2% of company | sold 1.6% | 2.77M | n/a | Jul 27, 26 |
Innovative Cellular Therapeutics Holdings Ltd Beneficial Owner (10%) | Sold (automatic/other) | -10 | sold <0.1% | 2.86M | $137 at $13.70 | Jul 17, 26 |
Innovative Cellular Therapeutics Holdings Ltd Beneficial Owner (10%) | Sold (automatic/other) | -10 | sold <0.1% | 2.86M | $137 at $13.73 | Jul 16, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on LYEL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LYEL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LYEL last traded at $8.56, down 0.58% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Lyell Immunopharma, Inc. Common Stock (LYEL) is next expected to report earnings on Wednesday, November 11, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LYEL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LYEL 12 times in the last 30 days.
LYEL (Lyell Immunopharma, Inc. Common Stock) trades on XNAS, with a market cap of about $211M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LYEL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LYEL discussion
Sign in to ask a question or join the discussion.